Verrica Pharmaceuticals Stock Technical Analysis
VRCA Stock | USD 7.06 0.06 0.86% |
As of the 18th of April 2024, Verrica Pharmaceuticals has the Semi Deviation of 4.0, coefficient of variation of 983.05, and Risk Adjusted Performance of 0.0725. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Verrica Pharmaceuticals, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to break down nineteen technical drivers for Verrica Pharmaceuticals, which can be compared to its competition. Please validate Verrica Pharmaceuticals value at risk, as well as the relationship between the semi variance and kurtosis to decide if Verrica Pharmaceuticals is priced more or less accurately, providing market reflects its prevalent price of 7.06 per share. Given that Verrica Pharmaceuticals has jensen alpha of 0.2898, we advise you to double-check Verrica Pharmaceuticals's current market performance to make sure the company can sustain itself at a future point.
Verrica Pharmaceuticals Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Verrica, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to VerricaVerrica |
Verrica Pharmaceuticals Analyst Consensus
Target Price | Advice | # of Analysts | |
12.67 | Strong Buy | 5 | Odds |
Most Verrica analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Verrica stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Verrica Pharmaceuticals, talking to its executives and customers, or listening to Verrica conference calls.
Verrica Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Verrica Pharmaceuticals Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Verrica Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Verrica Pharmaceuticals Trend Analysis
Use this graph to draw trend lines for Verrica Pharmaceuticals. You can use it to identify possible trend reversals for Verrica Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Verrica Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Verrica Pharmaceuticals Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Verrica Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of 0.02 , which means Verrica Pharmaceuticals will continue generating value for investors. It has 122 observation points and a regression sum of squares at 14.7, which is the sum of squared deviations for the predicted Verrica Pharmaceuticals price change compared to its average price change.About Verrica Pharmaceuticals Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Verrica Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Verrica Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Verrica Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Verrica Pharmaceuticals. By analyzing Verrica Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Verrica Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Verrica Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
2023 | 2024 (projected) | Graham Number | 3.81 | 4.61 | Receivables Turnover | 1.16 | 1.1 |
Verrica Pharmaceuticals April 18, 2024 Technical Indicators
Most technical analysis of Verrica help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Verrica from various momentum indicators to cycle indicators. When you analyze Verrica charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Risk Adjusted Performance | 0.0725 | |||
Market Risk Adjusted Performance | 0.1951 | |||
Mean Deviation | 3.08 | |||
Semi Deviation | 4.0 | |||
Downside Deviation | 4.35 | |||
Coefficient Of Variation | 983.05 | |||
Standard Deviation | 3.88 | |||
Variance | 15.02 | |||
Information Ratio | 0.0874 | |||
Jensen Alpha | 0.2898 | |||
Total Risk Alpha | 0.1046 | |||
Sortino Ratio | 0.0779 | |||
Treynor Ratio | 0.1851 | |||
Maximum Drawdown | 18.08 | |||
Value At Risk | (7.39) | |||
Potential Upside | 5.3 | |||
Downside Variance | 18.9 | |||
Semi Variance | 15.98 | |||
Expected Short fall | (3.30) | |||
Skewness | (0.56) | |||
Kurtosis | (0.07) |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Verrica Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For information on how to trade Verrica Stock refer to our How to Trade Verrica Stock guide.Note that the Verrica Pharmaceuticals information on this page should be used as a complementary analysis to other Verrica Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Complementary Tools for Verrica Stock analysis
When running Verrica Pharmaceuticals' price analysis, check to measure Verrica Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verrica Pharmaceuticals is operating at the current time. Most of Verrica Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Verrica Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Verrica Pharmaceuticals' price. Additionally, you may evaluate how the addition of Verrica Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Equity Valuation Check real value of public entities based on technical and fundamental data |
Is Verrica Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Verrica Pharmaceuticals. If investors know Verrica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Verrica Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.48) | Revenue Per Share 0.113 | Quarterly Revenue Growth 28.235 | Return On Assets (0.63) | Return On Equity (2.24) |
The market value of Verrica Pharmaceuticals is measured differently than its book value, which is the value of Verrica that is recorded on the company's balance sheet. Investors also form their own opinion of Verrica Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Verrica Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verrica Pharmaceuticals' market value can be influenced by many factors that don't directly affect Verrica Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Verrica Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Verrica Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verrica Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.